Credit: Sundry Photography via Shutterstock. Boston Scientific has resumed enrolment for its AVANT GUARD clinical trial, after it was paused in October 2024to “assess a few unanticipated observations” ...
Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy. Now, it has resumed its work to see whether its Farapulse platform can ...
The Identity pacemaker models 5370 and 5376 feature AF management, a suite of therapeutic and diagnostic capabilities designed to manage pacemaker patients suffering from AF. This tool kit includes: ...
Being unable to accurately or comfortably assess profit margin is another hurdle to building much-needed housing in the Boston area, she said. “Developers must understand the costs of ...
His next chance to play will be Saturday against the Raptors. Springer's absence hasn't impacted Boston's rotation. This was an expected move, as the Celtics are going to exercise caution on the ...
Read the Market Summary Here @- Global Cardiac Resynchronization Therapy (CRT) Devices Market Size Booming at Healthy CAGR of 8.4% to Touch USD 11.6 Billion by 2030 Global Cardiac Resynchronization ...
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...